PRDS logo

Pardes Biosciences, Inc. Stock Price

NasdaqGM:PRDS Community·US$131.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PRDS Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

PRDS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

3 Risks
0 Rewards

Pardes Biosciences, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$76.1m

Other Expenses

-US$76.1m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
-1.25
0%
0%
0%
View Full Analysis

About PRDS

Founded
2020
Employees
57
CEO
Thomas Wiggans
WebsiteView website
www.pardesbio.com

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.

Recent PRDS News & Updates

Recent updates

No updates